Seasonal COVID-19 Vaccination in 2025/26 Reduced Risk of Illness by Half in Canada

Seasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada

An interim analysis published in Eurosurveillance estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, offering protection beyond the vaccine's target strain.

Seasonal COVID-19 Vaccination in 2025/26 Halves Illness Risk in Canada

A recent interim analysis published in the esteemed journal Eurosurveillance has shed new light on the efficacy of the COVID-19 vaccine for the 2025/26 season in Canada, highlighting a remarkable reduction in illness risk by approximately fifty percent at nine weeks post-vaccination. This pivotal study not only underscores the vaccine’s protection against its designated LP.8.1 […]